Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
Muthiah Vaduganathan, Orly Vardeny, Thomas Michel, John J.V. McMurray, Marc A. Pfeffer, Scott D. Solomon
Abstract
RAAS Inhibitors in Patients with Covid-19 The effects of renin–angiotensin–aldosterone system blockers on angiotensin-converting enzyme 2 levels and activity in humans are uncertain. The authors hy...
Topics & Concepts
Renin–angiotensin systemAldosteroneCoronavirus disease 2019 (COVID-19)Internal medicineMedicinePeptidyl-Dipeptidase AAngiotensin-converting enzyme 2Angiotensin-converting enzymePharmacologyEndocrinologyBlood pressureDiseaseInfectious disease (medical specialty)Hormonal Regulation and HypertensionCOVID-19 Clinical Research StudiesRenin-Angiotensin System Studies